Researchers from the Cochrane collaboration conducted an extensive analysis of 80 major clinical trials involving nearly 30,000 participants to evaluate smoking cessation methods. The review determined that nicotine-containing e-cigarettes demonstrated superior effectiveness compared to conventional smoking cessation tools, including nicotine patches, gum, and behavioral support programs, with success rates improving to approximately one in every ten smokers from baseline rates of around six in every 100.
The analysis also found that nicotine vapes outperformed non-nicotine alternatives, though researchers suggested that switching to non-nicotine versions after initial success might facilitate further nicotine weaning. The findings indicate potential advantages over cytisine, a newer anti-smoking medication that the NHS has begun distributing, though additional research is needed for definitive comparisons. Experts emphasize that while vaping carries some health risks, the dangers are substantially lower than those associated with smoking.
The review focused exclusively on regulated e-cigarette products that meet quality standards and safety compliance requirements in their respective jurisdictions. It excluded unregulated devices that may contain illicit substances or pose safety hazards such as unstable batteries. Dr. Jamie Hartmann-Boyce, one of the report’s authors, warned consumers to only purchase regulatory-approved devices.
The analysis identified no evidence of increased serious harm risk from using e-cigarettes for smoking cessation. However, long-term vaping effects remain unclear, and health authorities advise against use among children and non-smokers. Current UK statistics indicate that vaping prevalence among adults exceeds smoking rates, with approximately 5.4 million adults using vapes compared to 5.3 million smokers. Most local NHS stop-smoking services now provide vape-based interventions as part of their cessation support offerings.
Article Attribution | Read More at Article Source
Article summary produced by Claude AI